Spectral Medical Inc.
EDTXF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$293.55M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $293.55 Million |
|---|---|
| Enterprise Value | $318.86 Million |
| Earnings per Share | $-0.16 |
| Beta | 0.21 |
| Outstanding Shares | 293,429,976 |
Return
| Return on Equity | 51.04% |
|---|---|
| Return on Assets | -1121.17% |
| Return on Invested Capital | 55.31% |
Valuation & Multiples
| P/E Ratio | -7.78 |
|---|---|
| PEG | 6.64 |
| Price to Sales | - |
| Price to Book Ratio | -0.65 |
| Enterprise Value to Revenue | 124.02 |
| Enterprise Value to EBIT | -9.77 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -0.37 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$425,216
Consensus analyst estimateNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.01
Consensus analyst estimateRevenue Estimate
$424,189
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Spectral Medical Inc.
29 employees
CEO: Chris Seto
Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid...